ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

216
Analysis
Health Care • South Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
bullish•Celltrion Inc
•24 Oct 2023 10:13

Celltrion Merger: Index Implications

Celltrion Inc (068270 KS) and Celltrion Healthcare (091990 KS) shareholders have approved the merger. The last trading day is expected to be 28...

Logo
1.3k Views
Share
bearish•Celltrion Inc
•24 Oct 2023 07:15

Celltrion Merger Swap Event: Trading Dynamics Post-Merger Approval

This post explores the trading dynamics after the Celltrion merger approval, where a notable spread widening is anticipated due to the higher cost...

Logo
706 Views
Share
bearish•Eoflow
•23 Oct 2023 17:14

Merger Arb Mondays (23 Oct) - Eoflow, Celltrion Healthcare, JSR, Origin, Lithium Power, Poly Culture

This week, the highest gross spreads are 111 (64.9%), Eoflow (38.2%), Hollysys (30.1%), JSR (8.2%), Haitong Intl (7.8%), LPI (7.5%), Orecorp...

Logo
827 Views
Share
•22 Oct 2023 07:00

(Mostly) Asia-Pac Weekly Risk Arb Wrap: Lithium Power, Vinda, Origin Energy, Liontown, Kenedix REITs

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
724 Views
Share
•16 Oct 2023 00:17

Merger Arb Mondays (16 Oct) - NWS, Haitong Intl, Eoflow, Liontown, Origin Energy, Estia, Pact, JSR

This week, the highest gross spreads are 111 (43.5%), Eoflow (38.2%), Hollysys (22.5%), Haitong Intl (8.6%), Orecorp (8.0%), Liontown (7.5%), JSR...

Logo
762 Views
Share
x